iwAL 2022 Session V: mechanisms of resistance to targeted therapies in AML
VJHemOnc Podcast
00:00
Testing for Flip Three Mutation in AML Patients and its Significance in Treatment
This chapter discusses the common use of PCR for detecting the flip three mutation in AML patients, emphasizing the importance of knowing the mutation status for effective treatment. It also highlights the evolving natural history of AML patients with flip three mutations and the need for ongoing trials and exploration of epigenetic sequencing in AML.
Transcript
Play full episode
